Eversept Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-205,815
Closed -$23.8M 80
2023
Q3
$23.8M Sell
205,815
-269,495
-57% -$29M 2.64% 13
2023
Q2
$48.9M Sell
475,310
-343,814
-42% -$36.3M 5.16% 7
2023
Q1
$89.4M Sell
819,124
-245,322
-23% -$27.1M 8.04% 5
2022
Q4
$121M Sell
1,064,446
-205,145
-16% -$17M 11.52% 2
2022
Q3
$78.6M Buy
1,269,591
+380,008
+43% +$26.6M 9.32% 4
2022
Q2
$71M Buy
889,583
+279,644
+46% +$26.5M 6.93% 5
2022
Q1
$64.2M Sell
609,939
-223,811
-27% -$21.8M 5.91% 5
2021
Q4
$89.8M Buy
833,750
+199,080
+31% +$21.7M 7.45% 2
2021
Q3
$69.5M Sell
634,670
-32,068
-5% -$3.33M 5.58% 4
2021
Q2
$62.4M Sell
666,738
-28,721
-4% -$2.64M 5.78% 6
2021
Q1
$64M Buy
695,459
+164,483
+31% +$13.9M 5.24% 5
2020
Q4
$38.8M Sell
530,976
-76,781
-13% -$5.71M 4.66% 6
2020
Q3
$47.2M Sell
607,757
-346,981
-36% -$23.9M 10.63% 1
2020
Q2
$53.1M Buy
+954,738
New +$40.8M 8.76% 2

Other funds holding HZNP